Pembrolizumab-Associated Seronegative Myasthenia Gravis in a Patient With Metastatic Renal Cell Carcinoma

Seronegative myasthenia gravis is a rare, but potential adverse effect of immune checkpoint inhibition. There have been few but increasing number of cases reported in recent years, and early recognition is important for prompt diagnosis and management. Here, we describe the case of a 65-year-old mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandya, Shaunak K, Ulrickson, Matthew, Dong, JiaXi, Willen, Ryan, Pandya, Arati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216640/
https://www.ncbi.nlm.nih.gov/pubmed/34178496
http://dx.doi.org/10.7759/cureus.15174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216640/
https://www.ncbi.nlm.nih.gov/pubmed/34178496
http://dx.doi.org/10.7759/cureus.15174

Ejemplares similares